Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study
FOWLER, Nathan, KAHL, Brad S, SALEH, Alfred, ROSEN, Peter, SHI, Hongliang, PARASURAMAN, Sudha, CHESON, Bruce D, LEE, Peter, MATOUS, Jeffrey V, CASHEN, Amanda F, JACOBS, Samuel A, LETZER, Jeffrey, AMIN, Bipinkumar, WILLIAMS, Michael E, SMITH, Sonali
Published in Journal of clinical oncology (01.09.2011)
Published in Journal of clinical oncology (01.09.2011)
Get full text
Journal Article
Capecitabine Plus Paclitaxel As Front-Line Combination Therapy for Metastatic Breast Cancer: A Multicenter Phase II Study
GRADISHAR, William J, MEZA, Luis A, AMIN, Bipinkumar, SAMID, Dvorit, HILL, Todd, CHEN, Yin-Miao, LOWER, Elyse E, MARCOM, P. Kelly
Published in Journal of clinical oncology (15.06.2004)
Published in Journal of clinical oncology (15.06.2004)
Get full text
Journal Article
A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib in combination with bendamustine and rituximab for previously untreated chronic lymphocytic leukemia
Salles, Gilles A., Lamanna, Nicole, Amin, Bipinkumar R., Boccia, Ralph V., Gabrail, Nashat Y., Zaydan, Muhammad-Ali A., Wong, Michelle, Adewoye, Adeboye H., Ghia, Paolo
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Bortezomib, Bendamustine, and Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma: Encouraging Activity in the Phase 2 VERTICAL Study
Fowler, Nathan, Kahl, Brad S, Rosen, Peter, Matous, Jeffrey, Cashen, Amanda, Jacobs, Samuel, Letzer, Jeffrey, Amin, Bipinkumar, Williams, Michael, Ross, Maureen, Smith, Sonali, Saleh, Alfred, Shi, Hongliang, Parasuraman, Sudha, Cheson, Bruce D.
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article